O95994	AGR2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Anterior gradient protein 2 homolog (AG-2) (hAG-2) (HPC8) (Secreted cement gland protein XAG-2 homolog)	AGR2 AG2 UNQ515/PRO1030	328;	9606.ENSP00000391490;
P31749	AKT1_HUMAN	reviewed	Evidence at protein level	5 out of 5	RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha)	AKT1 PKB RAC	391;	9606.ENSP00000451828;
P31751	AKT2_HUMAN	reviewed	Evidence at protein level	5 out of 5	RAC-beta serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase Akt-2) (Protein kinase B beta) (PKB beta) (RAC-PK-beta)	AKT2	392;	9606.ENSP00000375892;
Q9UKF5	ADA29_HUMAN	reviewed	Evidence at protein level	5 out of 5	Disintegrin and metalloproteinase domain-containing protein 29 (ADAM 29) (Cancer/testis antigen 73) (CT73)	ADAM29	207;	9606.ENSP00000484862;
Q01844	EWS_HUMAN	reviewed	Evidence at protein level	5 out of 5	RNA-binding protein EWS (EWS oncogene) (Ewing sarcoma breakpoint region 1 protein)	EWSR1 EWS	3508;	9606.ENSP00000400142;
P04626	ERBB2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Receptor tyrosine-protein kinase erbB-2 (EC 2.7.10.1) (Metastatic lymph node gene 19 protein) (MLN 19) (Proto-oncogene Neu) (Proto-oncogene c-ErbB-2) (Tyrosine kinase-type cell surface receptor HER2) (p185erbB2) (CD antigen CD340)	ERBB2 HER2 MLN19 NEU NGL	3430;	9606.ENSP00000269571;
O95936	EOMES_HUMAN	reviewed	Evidence at protein level	5 out of 5	Eomesodermin homolog (T-box brain protein 2) (T-brain-2) (TBR-2)	EOMES TBR2	3372;	9606.ENSP00000388620;
Q09472	EP300_HUMAN	reviewed	Evidence at protein level	5 out of 5	Histone acetyltransferase p300 (p300 HAT) (EC 2.3.1.48) (E1A-associated protein p300) (Histone butyryltransferase p300) (EC 2.3.1.-) (Histone crotonyltransferase p300) (EC 2.3.1.-) (Protein 2-hydroxyisobutyryltransferase p300) (EC 2.3.1.-) (Protein lactyltransferas p300) (EC 2.3.1.-) (Protein propionyltransferase p300) (EC 2.3.1.-)	EP300 P300	3373;	9606.ENSP00000263253;
O43709	BUD23_HUMAN	reviewed	Evidence at protein level	5 out of 5	Probable 18S rRNA (guanine-N(7))-methyltransferase (EC 2.1.1.-) (Bud site selection protein 23 homolog) (Metastasis-related methyltransferase 1) (Williams-Beuren syndrome chromosomal region 22 protein) (rRNA methyltransferase and ribosome maturation factor)	BUD23 MERM1 WBSCR22 HUSSY-03 PP3381	16405;	9606.ENSP00000401191;
Q9Y5Z0	BACE2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Beta-secretase 2 (EC 3.4.23.45) (Aspartic-like protease 56 kDa) (Aspartyl protease 1) (ASP1) (Asp 1) (Beta-site amyloid precursor protein cleaving enzyme 2) (Beta-site APP cleaving enzyme 2) (Down region aspartic protease) (DRAP) (Memapsin-1) (Membrane-associated aspartic protease 1) (Theta-secretase)	BACE2 AEPLC ALP56 ASP21 CDA13 UNQ418/PRO852	934;	9606.ENSP00000332979;
P15291	B4GT1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase) (Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase) (EC 2.4.1.38) (Lactose synthase A protein) (EC 2.4.1.22) (N-acetyllactosamine synthase) (EC 2.4.1.90) (Nal synthase) (Neolactotriaosylceramide beta-1,4-galactosyltransferase) (EC 2.4.1.275) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1]	B4GALT1 GGTB2	924;	9606.ENSP00000369055;
Q13015	AF1Q_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein AF1q	MLLT11 AF1Q	16997;	9606.ENSP00000357917;
P29374	ARI4A_HUMAN	reviewed	Evidence at protein level	5 out of 5	AT-rich interactive domain-containing protein 4A (ARID domain-containing protein 4A) (Retinoblastoma-binding protein 1) (RBBP-1)	ARID4A RBBP1 RBP1	9885;	9606.ENSP00000347602;
Q92754	AP2C_HUMAN	reviewed	Evidence at protein level	5 out of 5	Transcription factor AP-2 gamma (AP2-gamma) (Activating enhancer-binding protein 2 gamma) (Transcription factor ERF-1)	TFAP2C	11744;	9606.ENSP00000201031;
P07858	CATB_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cathepsin B (EC 3.4.22.1) (APP secretase) (APPS) (Cathepsin B1) [Cleaved into: Cathepsin B light chain; Cathepsin B heavy chain]	CTSB CPSB	2527;	9606.ENSP00000345672;
Q13363	CTBP1_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-terminal-binding protein 1 (CtBP1) (EC 1.1.1.-)	CTBP1 CTBP	2494;	9606.ENSP00000290921;
P45973	CBX5_HUMAN	reviewed	Evidence at protein level	5 out of 5	Chromobox protein homolog 5 (Antigen p25) (Heterochromatin protein 1 homolog alpha) (HP1 alpha)	CBX5 HP1A	1555;	9606.ENSP00000209875;
Q9H2U9	ADAM7_HUMAN	reviewed	Evidence at protein level	5 out of 5	Disintegrin and metalloproteinase domain-containing protein 7 (ADAM 7) (Sperm maturation-related glycoprotein GP-83)	ADAM7 GP83	214;	9606.ENSP00000175238;
Q9H5V8	CDCP1_HUMAN	reviewed	Evidence at protein level	5 out of 5	CUB domain-containing protein 1 (Membrane glycoprotein gp140) (Subtractive immunization M plus HEp3-associated 135 kDa protein) (SIMA135) (Transmembrane and associated with src kinases) (CD antigen CD318)	CDCP1 TRASK UNQ2486/PRO5773	24357;	9606.ENSP00000296129;
Q2M3G0	ABCB5_HUMAN	reviewed	Evidence at protein level	5 out of 5	ATP-binding cassette sub-family B member 5 (ABCB5 P-gp) (P-glycoprotein ABCB5) (EC 7.6.2.2)	ABCB5	46;	9606.ENSP00000384881;
Q8TD06	AGR3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Anterior gradient protein 3 (AG-3) (AG3) (hAG-3) (Anterior gradient 3 homolog) (Breast cancer membrane protein 11) (Protein disulfide isomerase family A, member 18)	AGR3 BCMP11 PDIA18 UNQ642/PRO1272	24167;	9606.ENSP00000308606;
O15144	ARPC2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Actin-related protein 2/3 complex subunit 2 (Arp2/3 complex 34 kDa subunit) (p34-ARC)	ARPC2 ARC34 PRO2446	705;	9606.ENSP00000295685;
Q8TAX9	GSDMB_HUMAN	reviewed	Evidence at protein level	5 out of 5	Gasdermin-B (Gasdermin-like protein) [Cleaved into: Gasdermin-B, N-terminal (GSDMB-NT) (p30); Gasdermin-B, C-terminal (GSDMB-CT) (p16)]	GSDMB GSDML PP4052 PRO2521	23690;	9606.ENSP00000415049;
Q8IZP9	AGRG2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Adhesion G-protein coupled receptor G2 (G-protein coupled receptor 64) (Human epididymis-specific protein 6) (He6)	ADGRG2 GPR64 HE6 TM7LN2	4516;	9606.ENSP00000369198;
Q12802	AKP13_HUMAN	reviewed	Evidence at protein level	5 out of 5	A-kinase anchor protein 13 (AKAP-13) (AKAP-Lbc) (Breast cancer nuclear receptor-binding auxiliary protein) (Guanine nucleotide exchange factor Lbc) (Human thyroid-anchoring protein 31) (Lymphoid blast crisis oncogene) (LBC oncogene) (Non-oncogenic Rho GTPase-specific GTP exchange factor) (Protein kinase A-anchoring protein 13) (PRKA13) (p47)	AKAP13 BRX HT31 LBC	371;	9606.ENSP00000354718;
Q13489	BIRC3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Baculoviral IAP repeat-containing protein 3 (EC 2.3.2.27) (Apoptosis inhibitor 2) (API2) (Cellular inhibitor of apoptosis 2) (C-IAP2) (IAP homolog C) (Inhibitor of apoptosis protein 1) (hIAP-1) (hIAP1) (RING finger protein 49) (RING-type E3 ubiquitin transferase BIRC3) (TNFR2-TRAF-signaling complex protein 1)	BIRC3 API2 MIHC RNF49	591;	9606.ENSP00000263464;
P15144	AMPN_HUMAN	reviewed	Evidence at protein level	5 out of 5	Aminopeptidase N (AP-N) (hAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Microsomal aminopeptidase) (Myeloid plasma membrane glycoprotein CD13) (gp150) (CD antigen CD13)	ANPEP APN CD13 PEPN	500;	9606.ENSP00000300060;
Q6PL18	ATAD2_HUMAN	reviewed	Evidence at protein level	5 out of 5	ATPase family AAA domain-containing protein 2 (EC 3.6.1.-) (AAA nuclear coregulator cancer-associated protein) (ANCCA)	ATAD2 L16 PRO2000	30123;	9606.ENSP00000287394;
Q9UK58	CCNL1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cyclin-L1 (Cyclin-L)	CCNL1 BM-001 UNQ530/PRO1073	20569;	9606.ENSP00000295926;
Q96DB9	FXYD5_HUMAN	reviewed	Evidence at protein level	5 out of 5	FXYD domain-containing ion transport regulator 5 (Dysadherin)	FXYD5 DYSAD IWU1 HSPC113 UNQ2561/PRO6241	4029;	9606.ENSP00000344254;
Q8IWG1	DNAI3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Dynein axonemal intermediate chain 3 (Testis development protein NYD-SP29) (WD repeat-containing protein 63)	DNAI3 WDR63	30711;	9606.ENSP00000294664;
Q96G23	CERS2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Ceramide synthase 2 (CerS2) (LAG1 longevity assurance homolog 2) (SP260) (Sphingosine N-acyltransferase CERS2) (EC 2.3.1.24) (Tumor metastasis-suppressor gene 1 protein) (Very-long-chain ceramide synthase CERS2) (EC 2.3.1.297)	CERS2 LASS2 TMSG1	14076;	9606.ENSP00000271688;
Q5T9G4	ARM12_HUMAN	reviewed	Evidence at protein level	5 out of 5	Armadillo repeat-containing protein 12	ARMC12 C6orf81	21099;	9606.ENSP00000288065;
P27701	CD82_HUMAN	reviewed	Evidence at protein level	5 out of 5	CD82 antigen (C33 antigen) (IA4) (Inducible membrane protein R2) (Metastasis suppressor Kangai-1) (Suppressor of tumorigenicity 6 protein) (Tetraspanin-27) (Tspan-27) (CD antigen CD82)	CD82 KAI1 SAR2 ST6 TSPAN27	6210;	9606.ENSP00000227155;
P08253	MMP2_HUMAN	reviewed	Evidence at protein level	5 out of 5	72 kDa type IV collagenase (EC 3.4.24.24) (72 kDa gelatinase) (Gelatinase A) (Matrix metalloproteinase-2) (MMP-2) (TBE-1) [Cleaved into: PEX]	MMP2 CLG4A	7166;	9606.ENSP00000219070;
P06748	NPM_HUMAN	reviewed	Evidence at protein level	5 out of 5	Nucleophosmin (NPM) (Nucleolar phosphoprotein B23) (Nucleolar protein NO38) (Numatrin)	NPM1 NPM	7910;	9606.ENSP00000296930;
P04049	RAF1_HUMAN	reviewed	Evidence at protein level	5 out of 5	RAF proto-oncogene serine/threonine-protein kinase (EC 2.7.11.1) (Proto-oncogene c-RAF) (cRaf) (Raf-1)	RAF1 RAF	9829;	9606.ENSP00000251849;
P01116	RASK_HUMAN	reviewed	Evidence at protein level	5 out of 5	GTPase KRas (EC 3.6.5.2) (K-Ras 2) (Ki-Ras) (c-K-ras) (c-Ki-ras) [Cleaved into: GTPase KRas, N-terminally processed]	KRAS KRAS2 RASK2	6407;	9606.ENSP00000256078;
Q9P258	RCC2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein RCC2 (RCC1-like protein TD-60) (Telophase disk protein of 60 kDa)	RCC2 KIAA1470 TD60	30297;	9606.ENSP00000364585;
O94776	MTA2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Metastasis-associated protein MTA2 (Metastasis-associated 1-like 1) (MTA1-L1 protein) (p53 target protein in deacetylase complex)	MTA2 MTA1L1 PID	7411;	9606.ENSP00000278823;
P63244	RACK1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Receptor of activated protein C kinase 1 (Cell proliferation-inducing gene 21 protein) (Guanine nucleotide-binding protein subunit beta-2-like 1) (Guanine nucleotide-binding protein subunit beta-like protein 12.3) (Human lung cancer oncogene 7 protein) (HLC-7) (Receptor for activated C kinase) (Small ribosomal subunit protein RACK1) [Cleaved into: Receptor of activated protein C kinase 1, N-terminally processed (Guanine nucleotide-binding protein subunit beta-2-like 1, N-terminally processed)]	RACK1 GNB2L1 HLC7 PIG21	4399;	9606.ENSP00000426909;
O95980	RECK_HUMAN	reviewed	Evidence at protein level	5 out of 5	Reversion-inducing cysteine-rich protein with Kazal motifs (hRECK) (Suppressor of tumorigenicity 15 protein)	RECK ST15	11345;	9606.ENSP00000367202;
P05556	ITB1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Integrin beta-1 (Fibronectin receptor subunit beta) (Glycoprotein IIa) (GPIIA) (VLA-4 subunit beta) (CD antigen CD29)	ITGB1 FNRB MDF2 MSK12	6153;	9606.ENSP00000379350;
P10914	IRF1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interferon regulatory factor 1 (IRF-1)	IRF1	6116;	9606.ENSP00000245414;
P09874	PARP1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Poly [ADP-ribose] polymerase 1 (PARP-1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 1) (ARTD1) (DNA ADP-ribosyltransferase PARP1) (EC 2.4.2.-) (NAD(+) ADP-ribosyltransferase 1) (ADPRT 1) (Poly[ADP-ribose] synthase 1) (Protein poly-ADP-ribosyltransferase PARP1) (EC 2.4.2.-)	PARP1 ADPRT PPOL	270;	9606.ENSP00000355759;
Q92932	PTPR2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Receptor-type tyrosine-protein phosphatase N2 (R-PTP-N2) (EC 3.1.3.-) (EC 3.1.3.48) (Islet cell autoantigen-related protein) (IAR) (ICAAR) (Phogrin) [Cleaved into: IA-2beta60]	PTPRN2 KIAA0387	9677;	9606.ENSP00000374069;
Q99732	LITAF_HUMAN	reviewed	Evidence at protein level	5 out of 5	Lipopolysaccharide-induced tumor necrosis factor-alpha factor (LPS-induced TNF-alpha factor) (Small integral membrane protein of lysosome/late endosome) (p53-induced gene 7 protein)	LITAF PIG7 SIMPLE	16841;	9606.ENSP00000459533;
P22392	NDKB_HUMAN	reviewed	Evidence at protein level	5 out of 5	Nucleoside diphosphate kinase B (NDK B) (NDP kinase B) (EC 2.7.4.6) (C-myc purine-binding transcription factor PUF) (Histidine protein kinase NDKB) (EC 2.7.13.3) (nm23-H2)	NME2 NM23B	7850;	9606.ENSP00000376886;
Q9P2A4	ABI3_HUMAN	reviewed	Evidence at protein level	5 out of 5	ABI gene family member 3 (New molecule including SH3) (Nesh)	ABI3 NESH	29859;	9606.ENSP00000225941;
P16234	PGFRA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Platelet-derived growth factor receptor alpha (PDGF-R-alpha) (PDGFR-alpha) (EC 2.7.10.1) (Alpha platelet-derived growth factor receptor) (Alpha-type platelet-derived growth factor receptor) (CD140 antigen-like family member A) (CD140a antigen) (Platelet-derived growth factor alpha receptor) (Platelet-derived growth factor receptor 2) (PDGFR-2) (CD antigen CD140a)	PDGFRA PDGFR2 RHEPDGFRA	8803;	9606.ENSP00000257290;
Q86TP1	PRUN1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Exopolyphosphatase PRUNE1 (EC 3.6.1.1) (Drosophila-related expressed sequence 17) (DRES-17) (DRES17) (HTcD37) (Protein prune homolog 1) (hPrune)	PRUNE1 PRUNE	13420;	9606.ENSP00000271620;
O76096	CYTF_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cystatin-F (Cystatin-7) (Cystatin-like metastasis-associated protein) (CMAP) (Leukocystatin)	CST7	2479;	9606.ENSP00000420384;
Q5VWQ8	DAB2P_HUMAN	reviewed	Evidence at protein level	5 out of 5	Disabled homolog 2-interacting protein (DAB2 interaction protein) (DAB2-interacting protein) (ASK-interacting protein 1) (AIP-1) (DOC-2/DAB-2 interactive protein)	DAB2IP AF9Q34 AIP1 KIAA1743	17294;	9606.ENSP00000259371;
Q92520	FAM3C_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein FAM3C (Interleukin-like EMT inducer)	FAM3C ILEI GS3786	18664;	9606.ENSP00000353025;
P14780	MMP9_HUMAN	reviewed	Evidence at protein level	5 out of 5	Matrix metalloproteinase-9 (MMP-9) (EC 3.4.24.35) (92 kDa gelatinase) (92 kDa type IV collagenase) (Gelatinase B) (GELB) [Cleaved into: 67 kDa matrix metalloproteinase-9; 82 kDa matrix metalloproteinase-9]	MMP9 CLG4B	7176;	9606.ENSP00000361405;
Q8WXI7	MUC16_HUMAN	reviewed	Evidence at protein level	5 out of 5	Mucin-16 (MUC-16) (Ovarian cancer-related tumor marker CA125) (CA-125) (Ovarian carcinoma antigen CA125)	MUC16 CA125	15582;	9606.ENSP00000381008;
P35222	CTNB1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Catenin beta-1 (Beta-catenin)	CTNNB1 CTNNB OK/SW-cl.35 PRO2286	2514;	9606.ENSP00000344456;
P43146	DCC_HUMAN	reviewed	Evidence at protein level	5 out of 5	Netrin receptor DCC (Colorectal cancer suppressor) (Immunoglobulin superfamily DCC subclass member 1) (Tumor suppressor protein DCC)	DCC IGDCC1	2701;	9606.ENSP00000389140;
Q15746	MYLK_HUMAN	reviewed	Evidence at protein level	5 out of 5	Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Kinase-related protein) (KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form]	MYLK MLCK MLCK1 MYLK1	7590;	9606.ENSP00000353452;
O75121	MFA3L_HUMAN	reviewed	Evidence at protein level	5 out of 5	Microfibrillar-associated protein 3-like (Testis development protein NYD-SP9)	MFAP3L KIAA0626 HSD-39 HSD39	29083;	9606.ENSP00000354583;
P56524	HDAC4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Histone deacetylase 4 (HD4) (EC 3.5.1.98)	HDAC4 KIAA0288	14063;	9606.ENSP00000264606;
P04196	HRG_HUMAN	reviewed	Evidence at protein level	5 out of 5	Histidine-rich glycoprotein (Histidine-proline-rich glycoprotein) (HPRG)	HRG	5181;	9606.ENSP00000232003;
P09429	HMGB1_HUMAN	reviewed	Evidence at protein level	5 out of 5	High mobility group protein B1 (High mobility group protein 1) (HMG-1)	HMGB1 HMG1	4983;	9606.ENSP00000345347;
Q9BUP3	HTAI2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Oxidoreductase HTATIP2 (EC 1.1.1.-) (30 kDa HIV-1 TAT-interacting protein) (HIV-1 TAT-interactive protein 2)	HTATIP2 CC3 TIP30	16637;	9606.ENSP00000392985;
P10721	KIT_HUMAN	reviewed	Evidence at protein level	5 out of 5	Mast/stem cell growth factor receptor Kit (SCFR) (EC 2.7.10.1) (Piebald trait protein) (PBT) (Proto-oncogene c-Kit) (Tyrosine-protein kinase Kit) (p145 c-kit) (v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog) (CD antigen CD117)	KIT SCFR	6342;	9606.ENSP00000288135;
Q9Y6Y0	NS1BP_HUMAN	reviewed	Evidence at protein level	5 out of 5	Influenza virus NS1A-binding protein (NS1-BP) (NS1-binding protein) (Aryl hydrocarbon receptor-associated protein 3) (Kelch-like protein 39)	IVNS1ABP ARA3 FLARA3 KIAA0850 KLHL39 NS1 NS1BP HSPC068	16951;	9606.ENSP00000356468;
Q13547	HDAC1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Histone deacetylase 1 (HD1) (EC 3.5.1.98) (Protein deacetylase HDAC1) (EC 3.5.1.-) (Protein decrotonylase HDAC1) (EC 3.5.1.-)	HDAC1 RPD3L1	4852;	9606.ENSP00000362649;
Q04900	MUC24_HUMAN	reviewed	Evidence at protein level	5 out of 5	Sialomucin core protein 24 (MUC-24) (Endolyn) (Multi-glycosylated core protein 24) (MGC-24) (MGC-24v) (CD antigen CD164)	CD164	1632;	9606.ENSP00000309376;
Q86W92	LIPB1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Liprin-beta-1 (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein-binding protein 1) (PTPRF-interacting protein-binding protein 1) (hSGT2)	PPFIBP1 KIAA1230	9249;	9606.ENSP00000314724;
P35637	FUS_HUMAN	reviewed	Evidence at protein level	5 out of 5	RNA-binding protein FUS (75 kDa DNA-pairing protein) (Oncogene FUS) (Oncogene TLS) (POMp75) (Translocated in liposarcoma protein)	FUS TLS	4010;	9606.ENSP00000254108;
Q92522	H1X_HUMAN	reviewed	Evidence at protein level	5 out of 5	Histone H1.10 (Histone H1x)	H1-10 H1FX	4722;	9606.ENSP00000329662;
Q16665	HIF1A_HUMAN	reviewed	Evidence at protein level	5 out of 5	Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein) (Basic-helix-loop-helix-PAS protein MOP1) (Class E basic helix-loop-helix protein 78) (bHLHe78) (Member of PAS protein 1) (PAS domain-containing protein 8)	HIF1A BHLHE78 MOP1 PASD8	4910;	9606.ENSP00000437955;
P40199	CEAM6_HUMAN	reviewed	Evidence at protein level	5 out of 5	Carcinoembryonic antigen-related cell adhesion molecule 6 (Non-specific crossreacting antigen) (Normal cross-reacting antigen) (CD antigen CD66c)	CEACAM6 NCA	1818;	9606.ENSP00000199764;
Q9BY66	KDM5D_HUMAN	reviewed	Evidence at protein level	5 out of 5	Lysine-specific demethylase 5D (EC 1.14.11.67) (Histocompatibility Y antigen) (H-Y) (Histone demethylase JARID1D) (Jumonji/ARID domain-containing protein 1D) (Protein SmcY) ([histone H3]-trimethyl-L-lysine(4) demethylase 5D)	KDM5D HY HYA JARID1D KIAA0234 SMCY	11115;	
P15941	MUC1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Mucin-1 (MUC-1) (Breast carcinoma-associated antigen DF3) (Cancer antigen 15-3) (CA 15-3) (Carcinoma-associated mucin) (Episialin) (H23AG) (Krebs von den Lungen-6) (KL-6) (PEMT) (Peanut-reactive urinary mucin) (PUM) (Polymorphic epithelial mucin) (PEM) (Tumor-associated epithelial membrane antigen) (EMA) (Tumor-associated mucin) (CD antigen CD227) [Cleaved into: Mucin-1 subunit alpha (MUC1-NT) (MUC1-alpha); Mucin-1 subunit beta (MUC1-beta) (MUC1-CT)]	MUC1 PUM	7508;	9606.ENSP00000484824;
Q9Y4K0	LOXL2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Lysyl oxidase homolog 2 (EC 1.4.3.13) (Lysyl oxidase-like protein 2) (Lysyl oxidase-related protein 2) (Lysyl oxidase-related protein WS9-14)	LOXL2	6666;	9606.ENSP00000373783;
Q14118	DAG1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Dystroglycan 1 (Dystroglycan) (Dystrophin-associated glycoprotein 1) [Cleaved into: Alpha-dystroglycan (Alpha-DG); Beta-dystroglycan (Beta-DG)]	DAG1	2666;	9606.ENSP00000442600;
P29323	EPHB2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Ephrin type-B receptor 2 (EC 2.7.10.1) (Developmentally-regulated Eph-related tyrosine kinase) (ELK-related tyrosine kinase) (EPH tyrosine kinase 3) (EPH-like kinase 5) (EK5) (hEK5) (Renal carcinoma antigen NY-REN-47) (Tyrosine-protein kinase TYRO5) (Tyrosine-protein kinase receptor EPH-3) [Cleaved into: EphB2/CTF1; EphB2/CTF2]	EPHB2 DRT EPHT3 EPTH3 ERK HEK5 TYRO5	3393;	9606.ENSP00000363763;
Q9H307	PININ_HUMAN	reviewed	Evidence at protein level	5 out of 5	Pinin (140 kDa nuclear and cell adhesion-related phosphoprotein) (Desmosome-associated protein) (Domain-rich serine protein) (DRS protein) (DRSP) (Melanoma metastasis clone A protein) (Nuclear protein SDK3) (SR-like protein)	PNN DRS MEMA	9162;	9606.ENSP00000216832;
Q9ULD0	OGDHL_HUMAN	reviewed	Evidence at protein level	5 out of 5	2-oxoglutarate dehydrogenase-like, mitochondrial (EC 1.2.4.2) (2-oxoglutarate dehydrogenase complex component E1-like) (OGDC-E1-like) (Alpha-ketoglutarate dehydrogenase-like)	OGDHL KIAA1290	25590;	9606.ENSP00000363216;
Q765P7	MTSS2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein MTSS 2 (Actin-bundling with BAIAP2 homology protein 1) (ABBA-1) (MTSS1-like protein)	MTSS2 MTSS1L	25094;	9606.ENSP00000341171;
O43312	MTSS1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein MTSS 1 (Metastasis suppressor YGL-1) (Metastasis suppressor protein 1) (Missing in metastasis protein)	MTSS1 KIAA0429 MIM	20443;	9606.ENSP00000322804;
P40261	NNMT_HUMAN	reviewed	Evidence at protein level	5 out of 5	Nicotinamide N-methyltransferase (EC 2.1.1.1)	NNMT	7861;	9606.ENSP00000441434;
Q96KR6	F210B_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein FAM210B, mitochondrial	FAM210B C20orf108 PSEC0265	16102;	9606.ENSP00000360437;
Q15726	KISS1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Metastasis-suppressor KiSS-1 (Kisspeptin-1) [Cleaved into: Metastin (Kisspeptin-54); Kisspeptin-14; Kisspeptin-13; Kisspeptin-10]	KISS1 PP5098	6341;	9606.ENSP00000356162;
Q969F8	KISSR_HUMAN	reviewed	Evidence at protein level	5 out of 5	KiSS-1 receptor (KiSS-1R) (G-protein coupled receptor 54) (G-protein coupled receptor OT7T175) (hOT7T175) (Hypogonadotropin-1) (Kisspeptins receptor) (Metastin receptor)	KISS1R AXOR12 GPR54	4510;	9606.ENSP00000234371;
Q9UK76	JUPI1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Jupiter microtubule associated homolog 1 (Androgen-regulated protein 2) (Hematological and neurological expressed 1 protein) [Cleaved into: Jupiter microtubule associated homolog 1, N-terminally processed]	JPT1 ARM2 HN1	14569;	9606.ENSP00000348316;
O95232	LC7L3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Luc7-like protein 3 (Cisplatin resistance-associated-overexpressed protein) (Luc7A) (Okadaic acid-inducible phosphoprotein OA48-18) (cAMP regulatory element-associated protein 1) (CRE-associated protein 1) (CREAP-1)	LUC7L3 CREAP1 CROP O48	24309;	9606.ENSP00000425092;
P35579	MYH9_HUMAN	reviewed	Evidence at protein level	5 out of 5	Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA)	MYH9	7579;	9606.ENSP00000216181;
P10275	ANDR_HUMAN	reviewed	Evidence at protein level	5 out of 5	Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4)	AR DHTR NR3C4	644;	9606.ENSP00000363822;
P04637	P53_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53)	TP53 P53	11998;	9606.ENSP00000269305;
Q14344	GNA13_HUMAN	reviewed	Evidence at protein level	5 out of 5	Guanine nucleotide-binding protein subunit alpha-13 (G alpha-13) (G-protein subunit alpha-13)	GNA13	4381;	9606.ENSP00000400717;
P18054	LOX12_HUMAN	reviewed	Evidence at protein level	5 out of 5	Polyunsaturated fatty acid lipoxygenase ALOX12 (EC 1.13.11.-) (Arachidonate (12S)-lipoxygenase) (12S-LOX) (12S-lipoxygenase) (EC 1.13.11.31) (Arachidonate (15S)-lipoxygenase) (EC 1.13.11.33) (Linoleate (13S)-lipoxygenase) (Lipoxin synthase 12-LO) (EC 3.3.2.-) (Platelet-type lipoxygenase 12)	ALOX12 12LO LOG12	429;	9606.ENSP00000251535;
Q9BRT3	MIEN1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Migration and invasion enhancer 1 (HBV X-transactivated gene 4 protein) (HBV XAg-transactivated protein 4) (Protein C35)	MIEN1 C17orf37 RDX12 XTP4	28230;	9606.ENSP00000377778;
P67775	PP2AA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform (PP2A-alpha) (EC 3.1.3.16) (Replication protein C) (RP-C)	PPP2CA	9299;	9606.ENSP00000418447;
Q8IZL8	PELP1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Proline-, glutamic acid- and leucine-rich protein 1 (Modulator of non-genomic activity of estrogen receptor) (Transcription factor HMX3)	PELP1 HMX3 MNAR	30134;	9606.ENSP00000301396;
P05387	RLA2_HUMAN	reviewed	Evidence at protein level	5 out of 5	60S acidic ribosomal protein P2 (Large ribosomal subunit protein P2) (Renal carcinoma antigen NY-REN-44)	RPLP2 D11S2243E RPP2	10377;	9606.ENSP00000322419;
Q86WR0	CCD25_HUMAN	reviewed	Evidence at protein level	5 out of 5	Coiled-coil domain-containing protein 25	CCDC25	25591;	9606.ENSP00000348933;
Q9Y251	HPSE_HUMAN	reviewed	Evidence at protein level	5 out of 5	Heparanase (EC 3.2.1.166) (Endo-glucoronidase) (Heparanase-1) (Hpa1) [Cleaved into: Heparanase 8 kDa subunit; Heparanase 50 kDa subunit]	HPSE HEP HPA HPA1 HPR1 HPSE1 HSE1	5164;	9606.ENSP00000384262;
O00425	IF2B3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Insulin-like growth factor 2 mRNA-binding protein 3 (IGF2 mRNA-binding protein 3) (IMP-3) (IGF-II mRNA-binding protein 3) (KH domain-containing protein overexpressed in cancer) (hKOC) (VICKZ family member 3)	IGF2BP3 IMP3 KOC1 VICKZ3	28868;	9606.ENSP00000258729;
O95274	LYPD3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Ly6/PLAUR domain-containing protein 3 (GPI-anchored metastasis-associated protein C4.4A homolog) (Matrigel-induced gene C4 protein) (MIG-C4)	LYPD3 C4.4A UNQ491/PRO1007	24880;	9606.ENSP00000244333;
P19338	NUCL_HUMAN	reviewed	Evidence at protein level	5 out of 5	Nucleolin (Protein C23)	NCL	7667;	9606.ENSP00000318195;
Q09028	RBBP4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Histone-binding protein RBBP4 (Chromatin assembly factor 1 subunit C) (CAF-1 subunit C) (Chromatin assembly factor I p48 subunit) (CAF-I 48 kDa subunit) (CAF-I p48) (Nucleosome-remodeling factor subunit RBAP48) (Retinoblastoma-binding protein 4) (RBBP-4) (Retinoblastoma-binding protein p48)	RBBP4 RBAP48	9887;	9606.ENSP00000362592;
Q16576	RBBP7_HUMAN	reviewed	Evidence at protein level	5 out of 5	Histone-binding protein RBBP7 (Histone acetyltransferase type B subunit 2) (Nucleosome-remodeling factor subunit RBAP46) (Retinoblastoma-binding protein 7) (RBBP-7) (Retinoblastoma-binding protein p46)	RBBP7 RBAP46	9890;	9606.ENSP00000369424;
O75330	HMMR_HUMAN	reviewed	Evidence at protein level	5 out of 5	Hyaluronan mediated motility receptor (Intracellular hyaluronic acid-binding protein) (Receptor for hyaluronan-mediated motility) (CD antigen CD168)	HMMR IHABP RHAMM	5012;	9606.ENSP00000377492;
Q13352	CENPR_HUMAN	reviewed	Evidence at protein level	5 out of 5	Centromere protein R (CENP-R) (Beta-3-endonexin) (Integrin beta-3-binding protein) (Nuclear receptor-interacting factor 3)	ITGB3BP CENPR NRIF3	6157;	9606.ENSP00000360133;
Q96EP1	CHFR_HUMAN	reviewed	Evidence at protein level	5 out of 5	E3 ubiquitin-protein ligase CHFR (EC 2.3.2.27) (Checkpoint with forkhead and RING finger domains protein) (RING finger protein 196) (RING-type E3 ubiquitin transferase CHFR)	CHFR RNF196	20455;	9606.ENSP00000392395;
P21926	CD9_HUMAN	reviewed	Evidence at protein level	5 out of 5	CD9 antigen (5H9 antigen) (Cell growth-inhibiting gene 2 protein) (Leukocyte antigen MIC3) (Motility-related protein) (MRP-1) (Tetraspanin-29) (Tspan-29) (p24) (CD antigen CD9)	CD9 MIC3 TSPAN29 GIG2	1709;	9606.ENSP00000371958;
P07333	CSF1R_HUMAN	reviewed	Evidence at protein level	5 out of 5	Macrophage colony-stimulating factor 1 receptor (CSF-1 receptor) (CSF-1-R) (CSF-1R) (M-CSF-R) (EC 2.7.10.1) (Proto-oncogene c-Fms) (CD antigen CD115)	CSF1R FMS	2433;	9606.ENSP00000286301;
Q969P0	IGSF8_HUMAN	reviewed	Evidence at protein level	5 out of 5	Immunoglobulin superfamily member 8 (IgSF8) (CD81 partner 3) (Glu-Trp-Ile EWI motif-containing protein 2) (EWI-2) (Keratinocytes-associated transmembrane protein 4) (KCT-4) (LIR-D1) (Prostaglandin regulatory-like protein) (PGRL) (CD antigen CD316)	IGSF8 CD81P3 EWI2 KCT4	17813;	9606.ENSP00000357065;
Q9Y2M5	KLH20_HUMAN	reviewed	Evidence at protein level	5 out of 5	Kelch-like protein 20 (Kelch-like ECT2-interacting protein) (Kelch-like protein X)	KLHL20 KLEIP KLHLX	25056;	9606.ENSP00000209884;
O15234	CASC3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein CASC3 (Cancer susceptibility candidate gene 3 protein) (Metastatic lymph node gene 51 protein) (MLN 51) (Protein barentsz) (Btz)	CASC3 MLN51	17040;	9606.ENSP00000264645;
P09603	CSF1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Macrophage colony-stimulating factor 1 (CSF-1) (M-CSF) (MCSF) (Lanimostim) [Cleaved into: Processed macrophage colony-stimulating factor 1]	CSF1	2432;	9606.ENSP00000327513;
P35221	CTNA1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Catenin alpha-1 (Alpha E-catenin) (Cadherin-associated protein) (Renal carcinoma antigen NY-REN-13)	CTNNA1	2509;	9606.ENSP00000304669;
Q16394	EXT1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Exostosin-1 (EC 2.4.1.224) (EC 2.4.1.225) (Glucuronosyl-N-acetylglucosaminyl-proteoglycan/N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase) (Multiple exostoses protein 1) (Putative tumor suppressor protein EXT1)	EXT1	3512;	9606.ENSP00000367446;
Q16658	FSCN1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Fascin (55 kDa actin-bundling protein) (Singed-like protein) (p55)	FSCN1 FAN1 HSN SNL	11148;	9606.ENSP00000371798;
Q13145	BAMBI_HUMAN	reviewed	Evidence at protein level	5 out of 5	BMP and activin membrane-bound inhibitor homolog (Non-metastatic gene A protein) (Putative transmembrane protein NMA)	BAMBI NMA	30251;	9606.ENSP00000364683;
Q53EU6	GPAT3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Glycerol-3-phosphate acyltransferase 3 (GPAT-3) (EC 2.3.1.15) (1-acyl-sn-glycerol-3-phosphate O-acyltransferase 10) (AGPAT 10) (1-acyl-sn-glycerol-3-phosphate O-acyltransferase 9) (1-AGP acyltransferase 9) (1-AGPAT 9) (EC 2.3.1.51) (Acyl-CoA:glycerol-3-phosphate acyltransferase 3) (hGPAT3) (Lung cancer metastasis-associated protein 1) (Lysophosphatidic acid acyltransferase theta) (LPAAT-theta) (MAG-1)	GPAT3 AGPAT9 MAG1 HMFN0839 UNQ2753/PRO6492	28157;	9606.ENSP00000482571;
P16591	FER_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tyrosine-protein kinase Fer (EC 2.7.10.2) (Feline encephalitis virus-related kinase FER) (Fujinami poultry sarcoma/Feline sarcoma-related protein Fer) (Proto-oncogene c-Fer) (Tyrosine kinase 3) (p94-Fer)	FER TYK3	3655;	9606.ENSP00000281092;
P02751	FINC_HUMAN	reviewed	Evidence at protein level	5 out of 5	Fibronectin (FN) (Cold-insoluble globulin) (CIG) [Cleaved into: Anastellin; Ugl-Y1; Ugl-Y2; Ugl-Y3]	FN1 FN	3778;	9606.ENSP00000346839;
Q9UNE7	CHIP_HUMAN	reviewed	Evidence at protein level	5 out of 5	E3 ubiquitin-protein ligase CHIP (EC 2.3.2.27) (Antigen NY-CO-7) (CLL-associated antigen KW-8) (Carboxy terminus of Hsp70-interacting protein) (RING-type E3 ubiquitin transferase CHIP) (STIP1 homology and U box-containing protein 1)	STUB1 CHIP PP1131	11427;	9606.ENSP00000219548;
P29317	EPHA2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Ephrin type-A receptor 2 (EC 2.7.10.1) (Epithelial cell kinase) (Tyrosine-protein kinase receptor ECK)	EPHA2 ECK	3386;	9606.ENSP00000351209;
Q13618	CUL3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cullin-3 (CUL-3)	CUL3 KIAA0617	2553;	9606.ENSP00000264414;
P05154	IPSP_HUMAN	reviewed	Evidence at protein level	5 out of 5	Plasma serine protease inhibitor (Acrosomal serine protease inhibitor) (Plasminogen activator inhibitor 3) (PAI-3) (PAI3) (Protein C inhibitor) (PCI) (Serpin A5)	SERPINA5 PCI PLANH3 PROCI	8723;	9606.ENSP00000333203;
Q13418	ILK_HUMAN	reviewed	Evidence at protein level	5 out of 5	Integrin-linked protein kinase (EC 2.7.11.1) (59 kDa serine/threonine-protein kinase) (Beta-integrin-linked kinase) (ILK-1) (ILK-2) (p59ILK)	ILK ILK1 ILK2	6040;	9606.ENSP00000379975;
Q6K0P9	IFIX_HUMAN	reviewed	Evidence at protein level	5 out of 5	Pyrin and HIN domain-containing protein 1 (Interferon-inducible protein X)	PYHIN1 IFIX	28894;	9606.ENSP00000357122;
P49841	GSK3B_HUMAN	reviewed	Evidence at protein level	5 out of 5	Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1)	GSK3B	4617;	9606.ENSP00000324806;
P35613	BASI_HUMAN	reviewed	Evidence at protein level	5 out of 5	Basigin (5F7) (Collagenase stimulatory factor) (Extracellular matrix metalloproteinase inducer) (EMMPRIN) (Hepatoma-associated antigen) (HAb18G) (Leukocyte activation antigen M6) (OK blood group antigen) (Tumor cell-derived collagenase stimulatory factor) (TCSF) (CD antigen CD147)	BSG UNQ6505/PRO21383	1116;	9606.ENSP00000333769;
Q9UBX1	CATF_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cathepsin F (CATSF) (EC 3.4.22.41)	CTSF	2531;	9606.ENSP00000310832;
P16870	CBPE_HUMAN	reviewed	Evidence at protein level	5 out of 5	Carboxypeptidase E (CPE) (EC 3.4.17.10) (Carboxypeptidase H) (CPH) (Enkephalin convertase) (Prohormone-processing carboxypeptidase)	CPE	2303;	9606.ENSP00000386104;
Q03113	GNA12_HUMAN	reviewed	Evidence at protein level	5 out of 5	Guanine nucleotide-binding protein subunit alpha-12 (G alpha-12) (G-protein subunit alpha-12)	GNA12	4380;	9606.ENSP00000275364;
Q9Y653	AGRG1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Adhesion G-protein coupled receptor G1 (G-protein coupled receptor 56) (Protein TM7XN1) [Cleaved into: ADGRG1 N-terminal fragment (ADGRG1 NT) (GPR56 N-terminal fragment) (GPR56 NT) (GPR56(N)) (GPR56 extracellular subunit) (GPR56 subunit alpha); ADGRG1 C-terminal fragment (ADGRG1 CT) (GPR56 C-terminal fragment) (GPR56 CT) (GPR56(C)) (GPR56 seven-transmembrane subunit) (GPR56 7TM) (GPR56 subunit beta)]	ADGRG1 GPR56 TM7LN4 TM7XN1 UNQ540/PRO1083	4512;	9606.ENSP00000455215;
Q9ULH1	ASAP1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 (130 kDa phosphatidylinositol 4,5-bisphosphate-dependent ARF1 GTPase-activating protein) (ADP-ribosylation factor-directed GTPase-activating protein 1) (ARF GTPase-activating protein 1) (Development and differentiation-enhancing factor 1) (DEF-1) (Differentiation-enhancing factor 1) (PIP2-dependent ARF1 GAP)	ASAP1 DDEF1 KIAA1249 PAG2	2720;	9606.ENSP00000429900;
P16220	CREB1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cyclic AMP-responsive element-binding protein 1 (CREB-1) (cAMP-responsive element-binding protein 1)	CREB1	2345;	9606.ENSP00000387699;
Q6ZN28	MACC1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Metastasis-associated in colon cancer protein 1 (SH3 domain-containing protein 7a5)	MACC1	30215;	9606.ENSP00000383185;
Q16666	IF16_HUMAN	reviewed	Evidence at protein level	5 out of 5	Gamma-interferon-inducible protein 16 (Ifi-16) (Interferon-inducible myeloid differentiation transcriptional activator)	IFI16 IFNGIP1	5395;	9606.ENSP00000357113;
Q86UE4	LYRIC_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein LYRIC (3D3/LYRIC) (Astrocyte elevated gene-1 protein) (AEG-1) (Lysine-rich CEACAM1 co-isolated protein) (Metadherin) (Metastasis adhesion protein)	MTDH AEG1 LYRIC	29608;	9606.ENSP00000338235;
P15848	ARSB_HUMAN	reviewed	Evidence at protein level	5 out of 5	Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S)	ARSB	714;	9606.ENSP00000264914;
Q9NV31	IMP3_HUMAN	reviewed	Evidence at protein level	5 out of 5	U3 small nucleolar ribonucleoprotein protein IMP3 (U3 snoRNP protein IMP3) (BRMS2)	IMP3 C15orf12 MRPS4	14497;	9606.ENSP00000326981;
P11279	LAMP1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Lysosome-associated membrane glycoprotein 1 (LAMP-1) (Lysosome-associated membrane protein 1) (CD107 antigen-like family member A) (CD antigen CD107a)	LAMP1	6499;	9606.ENSP00000333298;
Q5PSV4	BRM1L_HUMAN	reviewed	Evidence at protein level	5 out of 5	Breast cancer metastasis-suppressor 1-like protein (BRMS1-homolog protein p40) (BRMS1-like protein p40)	BRMS1L	20512;	9606.ENSP00000216807;
Q92851	CASPA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Caspase-10 (CASP-10) (EC 3.4.22.63) (Apoptotic protease Mch-4) (FAS-associated death domain protein interleukin-1B-converting enzyme 2) (FLICE2) (ICE-like apoptotic protease 4) [Cleaved into: Caspase-10 subunit p23/17; Caspase-10 subunit p12]	CASP10 MCH4	1500;	9606.ENSP00000286186;
Q9NUQ9	CYRIB_HUMAN	reviewed	Evidence at protein level	5 out of 5	CYFIP-related Rac1 interactor B (L1)	CYRIB CYRI FAM49B BM-009	25216;	9606.ENSP00000429150;
Q96GL9	F163A_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein FAM163A (Cebelin) (Neuroblastoma-derived secretory protein)	FAM163A C1orf76 NDSP	28274;	9606.ENSP00000354891;
Q9UQL6	HDAC5_HUMAN	reviewed	Evidence at protein level	5 out of 5	Histone deacetylase 5 (HD5) (EC 3.5.1.98) (Antigen NY-CO-9)	HDAC5 KIAA0600	14068;	9606.ENSP00000225983;
Q9UBN7	HDAC6_HUMAN	reviewed	Evidence at protein level	5 out of 5	Histone deacetylase 6 (HD6) (EC 3.5.1.98) (Tubulin-lysine deacetylase HDAC6) (EC 3.5.1.-)	HDAC6 KIAA0901 JM21	14064;	9606.ENSP00000334061;
Q14289	FAK2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein-tyrosine kinase 2-beta (EC 2.7.10.2) (Calcium-dependent tyrosine kinase) (CADTK) (Calcium-regulated non-receptor proline-rich tyrosine kinase) (Cell adhesion kinase beta) (CAK-beta) (CAKB) (Focal adhesion kinase 2) (FADK 2) (Proline-rich tyrosine kinase 2) (Related adhesion focal tyrosine kinase) (RAFTK)	PTK2B FAK2 PYK2 RAFTK	9612;	9606.ENSP00000380638;
Q92769	HDAC2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Histone deacetylase 2 (HD2) (EC 3.5.1.98) (Protein deacylase HDAC2) (EC 3.5.1.-)	HDAC2	4853;	9606.ENSP00000430432;
Q6ZMB0	B3GN6_HUMAN	reviewed	Evidence at protein level	5 out of 5	Acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase (EC 2.4.1.147) (Core 3 synthase) (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6) (BGnT-6) (Beta-1,3-Gn-T6) (Beta-1,3-N-acetylglucosaminyltransferase 6) (Beta3Gn-T6)	B3GNT6	24141;	9606.ENSP00000484640;
Q9ULU4	PKCB1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein kinase C-binding protein 1 (Cutaneous T-cell lymphoma-associated antigen se14-3) (CTCL-associated antigen se14-3) (Rack7) (Zinc finger MYND domain-containing protein 8)	ZMYND8 KIAA1125 PRKCBP1 RACK7	9397;	9606.ENSP00000420095;
O43653	PSCA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Prostate stem cell antigen	PSCA UNQ206/PRO232	9500;	9606.ENSP00000301258;
Q13740	CD166_HUMAN	reviewed	Evidence at protein level	5 out of 5	CD166 antigen (Activated leukocyte cell adhesion molecule) (CD antigen CD166)	ALCAM MEMD	400;	9606.ENSP00000305988;
Q16617	NKG7_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein NKG7 (G-CSF-induced gene 1 protein) (GIG-1 protein) (Granule membrane protein of 17 kDa) (GMP-17) (Natural killer cell protein 7) (p15-TIA-1)	NKG7 GIG1	7830;	9606.ENSP00000221978;
Q13822	ENPP2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 (E-NPP 2) (EC 3.1.4.39) (Autotaxin) (Extracellular lysophospholipase D) (LysoPLD)	ENPP2 ATX PDNP2	3357;	9606.ENSP00000259486;
Q14194	DPYL1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Dihydropyrimidinase-related protein 1 (DRP-1) (Collapsin response mediator protein 1) (CRMP-1) (Inactive dihydropyrimidinase) (Unc-33-like phosphoprotein 3) (ULIP-3)	CRMP1 DPYSL1 ULIP3	2365;	9606.ENSP00000321606;
P12830	CADH1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cadherin-1 (CAM 120/80) (Epithelial cadherin) (E-cadherin) (Uvomorulin) (CD antigen CD324) [Cleaved into: E-Cad/CTF1; E-Cad/CTF2; E-Cad/CTF3]	CDH1 CDHE UVO	1748;	9606.ENSP00000261769;
O14713	ITBP1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Integrin beta-1-binding protein 1 (Integrin cytoplasmic domain-associated protein 1) (ICAP-1)	ITGB1BP1 ICAP1	23927;	9606.ENSP00000353850;
Q15262	PTPRK_HUMAN	reviewed	Evidence at protein level	5 out of 5	Receptor-type tyrosine-protein phosphatase kappa (Protein-tyrosine phosphatase kappa) (R-PTP-kappa) (EC 3.1.3.48)	PTPRK PTPK	9674;	9606.ENSP00000357196;
A0JLT2	MED19_HUMAN	reviewed	Evidence at protein level	5 out of 5	Mediator of RNA polymerase II transcription subunit 19 (Lung cancer metastasis-related protein 1) (Mediator complex subunit 19)	MED19 LCMR1	29600;	9606.ENSP00000337340;
Q96RQ9	OXLA_HUMAN	reviewed	Evidence at protein level	5 out of 5	L-amino-acid oxidase (LAAO) (LAO) (EC 1.4.3.2) (EC 1.4.3.25) (Interleukin-4-induced protein 1) (IL4-induced protein 1) (hIL4I1) (Protein Fig-1) (hFIG1)	IL4I1 FIG1 UNQ636/PRO1265	19094;	9606.ENSP00000472474;
Q9BTL4	IER2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Immediate early response gene 2 protein (Protein ETR101)	IER2 ETR101 PIP92	28871;	9606.ENSP00000465617;
Q15743	OGR1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Ovarian cancer G-protein coupled receptor 1 (OGR-1) (G-protein coupled receptor 68) (GPR12A) (Sphingosylphosphorylcholine receptor)	GPR68 OGR1	4519;	9606.ENSP00000434045;
P43121	MUC18_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cell surface glycoprotein MUC18 (Cell surface glycoprotein P1H12) (Melanoma cell adhesion molecule) (Melanoma-associated antigen A32) (Melanoma-associated antigen MUC18) (S-endo 1 endothelial-associated antigen) (CD antigen CD146)	MCAM MUC18	6934;	9606.ENSP00000264036;
O00167	EYA2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Eyes absent homolog 2 (EC 3.1.3.48)	EYA2 EAB1	3520;	9606.ENSP00000333640;
Q9BTC8	MTA3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Metastasis-associated protein MTA3	MTA3 KIAA1266	23784;	9606.ENSP00000383973;
P08581	MET_HUMAN	reviewed	Evidence at protein level	5 out of 5	Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)	MET	7029;	9606.ENSP00000317272;
P08865	RSSA_HUMAN	reviewed	Evidence at protein level	5 out of 5	40S ribosomal protein SA (37 kDa laminin receptor precursor) (37LRP) (37/67 kDa laminin receptor) (LRP/LR) (67 kDa laminin receptor) (67LR) (Colon carcinoma laminin-binding protein) (Laminin receptor 1) (LamR) (Laminin-binding protein precursor p40) (LBP/p40) (Multidrug resistance-associated protein MGr1-Ag) (NEM/1CHD4) (Small ribosomal subunit protein uS2)	RPSA LAMBR LAMR1	6502;	9606.ENSP00000346067;
Q9HC62	SENP2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Sentrin-specific protease 2 (EC 3.4.22.-) (Axam2) (SMT3-specific isopeptidase 2) (Smt3ip2) (Sentrin/SUMO-specific protease SENP2)	SENP2 KIAA1331	23116;	9606.ENSP00000296257;
O75691	UTP20_HUMAN	reviewed	Evidence at protein level	5 out of 5	Small subunit processome component 20 homolog (Down-regulated in metastasis protein) (Novel nucleolar protein 73) (NNP73) (Protein Key-1A6)	UTP20 DRIM	17897;	9606.ENSP00000261637;
Q9NQ50	RM40_HUMAN	reviewed	Evidence at protein level	5 out of 5	39S ribosomal protein L40, mitochondrial (L40mt) (MRP-L40) (Mitochondrial large ribosomal subunit protein mL40) (Nuclear localization signal-containing protein deleted in velocardiofacial syndrome) (Up-regulated in metastasis)	MRPL40 NLVCF URIM	14491;	9606.ENSP00000333401;
P61586	RHOA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Transforming protein RhoA (EC 3.6.5.2) (Rho cDNA clone 12) (h12)	RHOA ARH12 ARHA RHO12	667;	9606.ENSP00000400175;
Q14684	RRP1B_HUMAN	reviewed	Evidence at protein level	5 out of 5	Ribosomal RNA processing protein 1 homolog B (RRP1-like protein B)	RRP1B KIAA0179	23818;	9606.ENSP00000339145;
Q9H4L7	SMRCD_HUMAN	reviewed	Evidence at protein level	5 out of 5	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1 (EC 3.6.4.12) (ATP-dependent helicase 1) (hHEL1)	SMARCAD1 KIAA1122	18398;	9606.ENSP00000351947;
Q0VAQ4	SMAGP_HUMAN	reviewed	Evidence at protein level	5 out of 5	Small cell adhesion glycoprotein (Small transmembrane and glycosylated protein)	SMAGP	26918;	9606.ENSP00000475068;
P15531	NDKA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Nucleoside diphosphate kinase A (NDK A) (NDP kinase A) (EC 2.7.4.6) (Granzyme A-activated DNase) (GAAD) (Metastasis inhibition factor nm23) (NM23-H1) (Tumor metastatic process-associated protein)	NME1 NDPKA NM23	7849;	9606.ENSP00000337060;
O60356	NUPR1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Nuclear protein 1 (Candidate of metastasis 1) (Protein p8)	NUPR1 COM1	29990;	
Q86YL7	PDPN_HUMAN	reviewed	Evidence at protein level	5 out of 5	Podoplanin (Aggrus) (Glycoprotein 36) (Gp36) (PA2.26 antigen) (T1-alpha) (T1A) [Cleaved into: 29kDa cytosolic podoplanin intracellular domain (PICD)]	PDPN GP36 PSEC0003 PSEC0025	29602;	9606.ENSP00000294489;
Q05397	FAK1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Focal adhesion kinase 1 (FADK 1) (EC 2.7.10.2) (Focal adhesion kinase-related nonkinase) (FRNK) (Protein phosphatase 1 regulatory subunit 71) (PPP1R71) (Protein-tyrosine kinase 2) (p125FAK) (pp125FAK)	PTK2 FAK FAK1	9611;	9606.ENSP00000341189;
Q92786	PROX1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Prospero homeobox protein 1 (Homeobox prospero-like protein PROX1) (PROX-1)	PROX1	9459;	9606.ENSP00000355925;
Q9Y6C5	PTC2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein patched homolog 2 (PTC2)	PTCH2 UNQ560/PRO1121/PRO57079	9586;	9606.ENSP00000361266;
Q8N488	RYBP_HUMAN	reviewed	Evidence at protein level	5 out of 5	RING1 and YY1-binding protein (Apoptin-associating protein 1) (APAP-1) (Death effector domain-associated factor) (DED-associated factor) (YY1 and E4TF1-associated factor 1)	RYBP DEDAF YEAF1	10480;	9606.ENSP00000419494;
O43623	SNAI2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Zinc finger protein SNAI2 (Neural crest transcription factor Slug) (Protein snail homolog 2)	SNAI2 SLUG SLUGH	11094;	9606.ENSP00000380034;
Q13635	PTC1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein patched homolog 1 (PTC) (PTC1)	PTCH1 PTCH	9585;	9606.ENSP00000332353;
Q9P0U3	SENP1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Sentrin-specific protease 1 (EC 3.4.22.-) (Sentrin/SUMO-specific protease SENP1)	SENP1	17927;	9606.ENSP00000394791;
Q8NDV1	SIA7C_HUMAN	reviewed	Evidence at protein level	5 out of 5	Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3 (EC 2.4.99.7) (GalNAc alpha-2,6-sialyltransferase III) (ST6GalNAc III) (ST6GalNAcIII) (STY) (Sialyltransferase 7C) (SIAT7-C)	ST6GALNAC3 SIAT7C UNQ2787/PRO7177	19343;	9606.ENSP00000329214;
Q969X2	SIA7F_HUMAN	reviewed	Evidence at protein level	5 out of 5	Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6 (EC 2.4.99.-) (GalNAc alpha-2,6-sialyltransferase VI) (ST6GalNAc VI) (ST6GalNAcVI) (hST6GalNAc VI) (Sialyltransferase 7F) (SIAT7-F)	ST6GALNAC6 SIAT7F UNQ708/PRO1359	23364;	9606.ENSP00000362235;
P57059	SIK1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Serine/threonine-protein kinase SIK1 (EC 2.7.11.1) (Salt-inducible kinase 1) (SIK-1) (Serine/threonine-protein kinase SNF1-like kinase 1) (Serine/threonine-protein kinase SNF1LK)	SIK1 SIK SNF1LK	11142;	9606.ENSP00000270162;
P26447	S10A4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein S100-A4 (Calvasculin) (Metastasin) (Placental calcium-binding protein) (Protein Mts1) (S100 calcium-binding protein A4)	S100A4 CAPL MTS1	10494;	9606.ENSP00000357705;
Q15475	SIX1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Homeobox protein SIX1 (Sine oculis homeobox homolog 1)	SIX1	10887;	9606.ENSP00000247182;
Q9BVH7	SIA7E_HUMAN	reviewed	Evidence at protein level	5 out of 5	Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 (EC 2.4.99.-) (GD1 alpha synthase) (GalNAc alpha-2,6-sialyltransferase V) (ST6GalNAc V) (ST6GalNAcV) (Sialyltransferase 7E) (SIAT7-E)	ST6GALNAC5 SIAT7E	19342;	9606.ENSP00000417583;
Q9UIF7	MUTYH_HUMAN	reviewed	Evidence at protein level	5 out of 5	Adenine DNA glycosylase (EC 3.2.2.31) (MutY homolog) (hMYH)	MUTYH MYH	7527;	9606.ENSP00000361170;
O60285	NUAK1_HUMAN	reviewed	Evidence at protein level	5 out of 5	NUAK family SNF1-like kinase 1 (EC 2.7.11.1) (AMPK-related protein kinase 5) (ARK5) (Omphalocele kinase 1)	NUAK1 ARK5 KIAA0537 OMPHK1	14311;	9606.ENSP00000261402;
Q14191	WRN_HUMAN	reviewed	Evidence at protein level	5 out of 5	Werner syndrome ATP-dependent helicase (EC 3.6.4.12) (DNA helicase, RecQ-like type 3) (RecQ3) (Exonuclease WRN) (EC 3.1.-.-) (RecQ protein-like 2)	WRN RECQ3 RECQL2	12791;	9606.ENSP00000298139;
P63165	SUMO1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Small ubiquitin-related modifier 1 (SUMO-1) (GAP-modifying protein 1) (GMP1) (SMT3 homolog 3) (Sentrin) (Ubiquitin-homology domain protein PIC1) (Ubiquitin-like protein SMT3C) (Smt3C) (Ubiquitin-like protein UBL1)	SUMO1 SMT3C SMT3H3 UBL1 OK/SW-cl.43	12502;	9606.ENSP00000376077;
Q15831	STK11_HUMAN	reviewed	Evidence at protein level	5 out of 5	Serine/threonine-protein kinase STK11 (EC 2.7.11.1) (Liver kinase B1) (LKB1) (hLKB1) (Renal carcinoma antigen NY-REN-19)	STK11 LKB1 PJS	11389;	9606.ENSP00000324856;
Q13330	MTA1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Metastasis-associated protein MTA1	MTA1	7410;	9606.ENSP00000333633;
O75925	PIAS1_HUMAN	reviewed	Evidence at protein level	5 out of 5	E3 SUMO-protein ligase PIAS1 (EC 2.3.2.-) (DEAD/H box-binding protein 1) (E3 SUMO-protein transferase PIAS1) (Gu-binding protein) (GBP) (Protein inhibitor of activated STAT protein 1) (RNA helicase II-binding protein)	PIAS1 DDXBP1	2752;	9606.ENSP00000249636;
P08047	SP1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Transcription factor Sp1	SP1 TSFP1	11205;	9606.ENSP00000329357;
O95379	TFIP8_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tumor necrosis factor alpha-induced protein 8 (TNF alpha-induced protein 8) (Head and neck tumor and metastasis-related protein) (MDC-3.13) (NF-kappa-B-inducible DED-containing protein) (NDED) (SCC-S2) (TNF-induced protein GG2-1)	TNFAIP8	17260;	9606.ENSP00000427424;
P00747	PLMN_HUMAN	reviewed	Evidence at protein level	5 out of 5	Plasminogen (EC 3.4.21.7) [Cleaved into: Plasmin heavy chain A; Activation peptide; Angiostatin; Plasmin heavy chain A, short form; Plasmin light chain B]	PLG	9071;	9606.ENSP00000308938;
O94875	SRBS2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Sorbin and SH3 domain-containing protein 2 (Arg-binding protein 2) (ArgBP2) (Arg/Abl-interacting protein 2) (Sorbin)	SORBS2 ARGBP2 KIAA0777	24098;	9606.ENSP00000347852;
Q01826	SATB1_HUMAN	reviewed	Evidence at protein level	5 out of 5	DNA-binding protein SATB1 (Special AT-rich sequence-binding protein 1)	SATB1	10541;	9606.ENSP00000399518;
O94993	SOX30_HUMAN	reviewed	Evidence at protein level	5 out of 5	Transcription factor SOX-30	SOX30	30635;	9606.ENSP00000265007;
Q9HCU9	BRMS1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Breast cancer metastasis-suppressor 1	BRMS1	17262;	9606.ENSP00000396052;
Q13490	BIRC2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Baculoviral IAP repeat-containing protein 2 (EC 2.3.2.27) (Cellular inhibitor of apoptosis 1) (C-IAP1) (IAP homolog B) (Inhibitor of apoptosis protein 2) (hIAP-2) (hIAP2) (RING finger protein 48) (RING-type E3 ubiquitin transferase BIRC2) (TNFR2-TRAF-signaling complex protein 2)	BIRC2 API1 MIHB RNF48	590;	9606.ENSP00000477613;
Q9UQB8	BAIP2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Brain-specific angiogenesis inhibitor 1-associated protein 2 (BAI-associated protein 2) (BAI1-associated protein 2) (Protein BAP2) (Fas ligand-associated factor 3) (FLAF3) (Insulin receptor substrate p53/p58) (IRS-58) (IRSp53/58) (Insulin receptor substrate protein of 53 kDa) (IRSp53) (Insulin receptor substrate p53)	BAIAP2	947;	9606.ENSP00000316338;
Q9UKV5	AMFR_HUMAN	reviewed	Evidence at protein level	5 out of 5	E3 ubiquitin-protein ligase AMFR (EC 2.3.2.36) (Autocrine motility factor receptor) (AMF receptor) (RING finger protein 45) (gp78)	AMFR RNF45	463;	9606.ENSP00000290649;
P25054	APC_HUMAN	reviewed	Evidence at protein level	5 out of 5	Adenomatous polyposis coli protein (Protein APC) (Deleted in polyposis 2.5)	APC DP2.5	583;	9606.ENSP00000257430;
P18846	ATF1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cyclic AMP-dependent transcription factor ATF-1 (cAMP-dependent transcription factor ATF-1) (Activating transcription factor 1) (Protein TREB36)	ATF1	783;	9606.ENSP00000262053;
Q9UQC9	CLCA2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Calcium-activated chloride channel regulator 2 (EC 3.4.-.-) (Calcium-activated chloride channel family member 2) (hCLCA2) (Calcium-activated chloride channel protein 3) (CaCC-3) (hCaCC-3) [Cleaved into: Calcium-activated chloride channel regulator 2, 109 kDa form; Calcium-activated chloride channel regulator 2, 35 kDa form]	CLCA2 CACC3	2016;	9606.ENSP00000359596;
Q96KP4	CNDP2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cytosolic non-specific dipeptidase (EC 3.4.13.18) (CNDP dipeptidase 2) (Glutamate carboxypeptidase-like protein 1) (Peptidase A) (Threonyl dipeptidase)	CNDP2 CN2 CPGL HEL-S-13 PEPA	24437;	9606.ENSP00000325548;
P55854	SUMO3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Small ubiquitin-related modifier 3 (SUMO-3) (SMT3 homolog 1) (SUMO-2) (Ubiquitin-like protein SMT3A) (Smt3A)	SUMO3 SMT3A SMT3H1	11124;	
Q9Y6X2	PIAS3_HUMAN	reviewed	Evidence at protein level	5 out of 5	E3 SUMO-protein ligase PIAS3 (EC 2.3.2.-) (E3 SUMO-protein transferase PIAS3) (Protein inhibitor of activated STAT protein 3)	PIAS3	16861;	9606.ENSP00000376765;
Q6J9G0	STYK1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tyrosine-protein kinase STYK1 (EC 2.7.10.2) (Novel oncogene with kinase domain) (Protein PK-unique) (Serine/threonine/tyrosine kinase 1)	STYK1 NOK	18889;	9606.ENSP00000075503;
O00584	RNT2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Ribonuclease T2 (EC 4.6.1.19) (Ribonuclease 6)	RNASET2 RNASE6PL	21686;	9606.ENSP00000426455;
O15205	UBD_HUMAN	reviewed	Evidence at protein level	5 out of 5	Ubiquitin D (Diubiquitin) (Ubiquitin-like protein FAT10)	UBD FAT10	18795;	9606.ENSP00000366249;
Q9H7S9	ZN703_HUMAN	reviewed	Evidence at protein level	5 out of 5	Zinc finger protein 703 (Zinc finger elbow-related proline domain protein 1)	ZNF703 ZEPPO1 ZPO1	25883;	9606.ENSP00000332325;
O15393	TMPS2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Transmembrane protease serine 2 (EC 3.4.21.-) (Serine protease 10) [Cleaved into: Transmembrane protease serine 2 non-catalytic chain; Transmembrane protease serine 2 catalytic chain]	TMPRSS2 PRSS10	11876;	9606.ENSP00000381588;
O75365	TP4A3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein tyrosine phosphatase type IVA 3 (EC 3.1.3.48) (PRL-R) (Protein-tyrosine phosphatase 4a3) (Protein-tyrosine phosphatase of regenerating liver 3) (PRL-3)	PTP4A3 PRL3	9636;	9606.ENSP00000332274;
P98170	XIAP_HUMAN	reviewed	Evidence at protein level	5 out of 5	E3 ubiquitin-protein ligase XIAP (EC 2.3.2.27) (Baculoviral IAP repeat-containing protein 4) (IAP-like protein) (ILP) (hILP) (Inhibitor of apoptosis protein 3) (IAP-3) (hIAP-3) (hIAP3) (RING-type E3 ubiquitin transferase XIAP) (X-linked inhibitor of apoptosis protein) (X-linked IAP)	XIAP API3 BIRC4 IAP3	592;	9606.ENSP00000360242;
P16989	YBOX3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Y-box-binding protein 3 (Cold shock domain-containing protein A) (DNA-binding protein A) (Single-strand DNA-binding protein NF-GMB)	YBX3 CSDA DBPA	2428;	9606.ENSP00000228251;
P63279	UBC9_HUMAN	reviewed	Evidence at protein level	5 out of 5	SUMO-conjugating enzyme UBC9 (EC 2.3.2.-) (RING-type E3 SUMO transferase UBC9) (SUMO-protein ligase) (Ubiquitin carrier protein 9) (Ubiquitin carrier protein I) (Ubiquitin-conjugating enzyme E2 I) (Ubiquitin-protein ligase I) (p18)	UBE2I UBC9 UBCE9	12485;	9606.ENSP00000348056;
Q13009	TIAM1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Rho guanine nucleotide exchange factor TIAM1 (T-lymphoma invasion and metastasis-inducing protein 1) (TIAM-1)	TIAM1	11805;	9606.ENSP00000286827;
P23921	RIR1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Ribonucleoside-diphosphate reductase large subunit (EC 1.17.4.1) (Ribonucleoside-diphosphate reductase subunit M1) (Ribonucleotide reductase large subunit)	RRM1 RR1	10451;	9606.ENSP00000300738;
P49763	PLGF_HUMAN	reviewed	Evidence at protein level	5 out of 5	Placenta growth factor (PlGF)	PGF PGFL PLGF	8893;	9606.ENSP00000451040;
Q14247	SRC8_HUMAN	reviewed	Evidence at protein level	5 out of 5	Src substrate cortactin (Amplaxin) (Oncogene EMS1)	CTTN EMS1	3338;	9606.ENSP00000365745;
O43791	SPOP_HUMAN	reviewed	Evidence at protein level	5 out of 5	Speckle-type POZ protein (HIB homolog 1) (Roadkill homolog 1)	SPOP	11254;	9606.ENSP00000377001;
Q9Y5Y6	ST14_HUMAN	reviewed	Evidence at protein level	5 out of 5	Suppressor of tumorigenicity 14 protein (EC 3.4.21.109) (Matriptase) (Membrane-type serine protease 1) (MT-SP1) (Prostamin) (Serine protease 14) (Serine protease TADG-15) (Tumor-associated differentially-expressed gene 15 protein)	ST14 PRSS14 SNC19 TADG15	11344;	9606.ENSP00000278742;
P35916	VGFR3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Vascular endothelial growth factor receptor 3 (VEGFR-3) (EC 2.7.10.1) (Fms-like tyrosine kinase 4) (FLT-4) (Tyrosine-protein kinase receptor FLT4)	FLT4 VEGFR3	3767;	9606.ENSP00000261937;
Q9NQB0	TF7L2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Transcription factor 7-like 2 (HMG box transcription factor 4) (T-cell-specific transcription factor 4) (T-cell factor 4) (TCF-4) (hTCF-4)	TCF7L2 TCF4	11641;	9606.ENSP00000358404;
Q8NEB5	PLPP5_HUMAN	reviewed	Evidence at protein level	5 out of 5	Phospholipid phosphatase 5 (EC 3.1.3.4) (EC 3.1.3.81) (Phosphatidic acid phosphatase type 2 domain-containing protein 1B)	PLPP5 DPPL1 HTPAP PPAPDC1B	25026;	9606.ENSP00000392553;
P61956	SUMO2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Small ubiquitin-related modifier 2 (SUMO-2) (HSMT3) (SMT3 homolog 2) (SUMO-3) (Sentrin-2) (Ubiquitin-like protein SMT3B) (Smt3B)	SUMO2 SMT3B SMT3H2	11125;	9606.ENSP00000405965;
P41221	WNT5A_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein Wnt-5a	WNT5A	12784;	9606.ENSP00000264634;
P19474	RO52_HUMAN	reviewed	Evidence at protein level	5 out of 5	E3 ubiquitin-protein ligase TRIM21 (EC 2.3.2.27) (52 kDa Ro protein) (52 kDa ribonucleoprotein autoantigen Ro/SS-A) (RING finger protein 81) (RING-type E3 ubiquitin transferase TRIM21) (Ro(SS-A)) (Sjoegren syndrome type A antigen) (SS-A) (Tripartite motif-containing protein 21)	TRIM21 RNF81 RO52 SSA1	11312;	9606.ENSP00000254436;
P36402	TCF7_HUMAN	reviewed	Evidence at protein level	5 out of 5	Transcription factor 7 (TCF-7) (T-cell-specific transcription factor 1) (T-cell factor 1) (TCF-1)	TCF7 TCF1	11639;	9606.ENSP00000340347;
Q8N2W9	PIAS4_HUMAN	reviewed	Evidence at protein level	5 out of 5	E3 SUMO-protein ligase PIAS4 (EC 2.3.2.27) (PIASy) (Protein inhibitor of activated STAT protein 4) (Protein inhibitor of activated STAT protein gamma) (PIAS-gamma)	PIAS4 PIASG	17002;	9606.ENSP00000262971;
Q9UNH7	SNX6_HUMAN	reviewed	Evidence at protein level	5 out of 5	Sorting nexin-6 (TRAF4-associated factor 2) [Cleaved into: Sorting nexin-6, N-terminally processed]	SNX6	14970;	9606.ENSP00000355217;
Q8IUG5	MY18B_HUMAN	reviewed	Evidence at protein level	5 out of 5	Unconventional myosin-XVIIIb	MYO18B	18150;	9606.ENSP00000334563;
Q7Z4N2	TRPM1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Transient receptor potential cation channel subfamily M member 1 (Long transient receptor potential channel 1) (LTrpC1) (Melastatin-1)	TRPM1 LTRPC1 MLSN MLSN1	7146;	9606.ENSP00000437849;
Q16763	UBE2S_HUMAN	reviewed	Evidence at protein level	5 out of 5	Ubiquitin-conjugating enzyme E2 S (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme S) (E2-EPF) (Ubiquitin carrier protein S) (Ubiquitin-conjugating enzyme E2-24 kDa) (Ubiquitin-conjugating enzyme E2-EPF5) (Ubiquitin-protein ligase S)	UBE2S E2EPF OK/SW-cl.73	17895;	9606.ENSP00000264552;
Q9BQ24	ZFY21_HUMAN	reviewed	Evidence at protein level	5 out of 5	Zinc finger FYVE domain-containing protein 21 (ZF21)	ZFYVE21	20760;	9606.ENSP00000216602;
Q07955	SRSF1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Serine/arginine-rich splicing factor 1 (Alternative-splicing factor 1) (ASF-1) (Splicing factor, arginine/serine-rich 1) (pre-mRNA-splicing factor SF2, P33 subunit)	SRSF1 ASF SF2 SF2P33 SFRS1 OK/SW-cl.3	10780;	9606.ENSP00000258962;
Q13641	TPBG_HUMAN	reviewed	Evidence at protein level	5 out of 5	Trophoblast glycoprotein (5T4 oncofetal antigen) (5T4 oncofetal trophoblast glycoprotein) (5T4 oncotrophoblast glycoprotein) (M6P1) (Wnt-activated inhibitory factor 1) (WAIF1)	TPBG 5T4	12004;	9606.ENSP00000358765;
A0A5B9	TRBC2_HUMAN	reviewed	Evidence at protein level	5 out of 5	T cell receptor beta constant 2	TRBC2 TCRBC2	12157;	
Q9UIJ5	ZDHC2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Palmitoyltransferase ZDHHC2 (EC 2.3.1.225) (Acyltransferase ZDHHC2) (EC 2.3.1.-) (Reduced expression associated with metastasis protein) (Ream) (Reduced expression in cancer protein) (Rec) (Zinc finger DHHC domain-containing protein 2) (DHHC-2) (Zinc finger protein 372)	ZDHHC2 REAM REC ZNF372	18469;	9606.ENSP00000262096;
Q8IUK5	PLDX1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Plexin domain-containing protein 1 (Tumor endothelial marker 3) (Tumor endothelial marker 7)	PLXDC1 TEM3 TEM7	20945;	9606.ENSP00000323927;
P35442	TSP2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Thrombospondin-2	THBS2 TSP2	11786;	9606.ENSP00000355751;
P17948	VGFR1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Vascular endothelial growth factor receptor 1 (VEGFR-1) (EC 2.7.10.1) (Fms-like tyrosine kinase 1) (FLT-1) (Tyrosine-protein kinase FRT) (Tyrosine-protein kinase receptor FLT) (FLT) (Vascular permeability factor receptor)	FLT1 FLT FRT VEGFR1	3763;	9606.ENSP00000282397;
Q04206	TF65_HUMAN	reviewed	Evidence at protein level	5 out of 5	Transcription factor p65 (Nuclear factor NF-kappa-B p65 subunit) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 3)	RELA NFKB3	9955;	9606.ENSP00000384273;
O14818	PSA7_HUMAN	reviewed	Evidence at protein level	5 out of 5	Proteasome subunit alpha type-7 (Proteasome subunit RC6-1) (Proteasome subunit XAPC7)	PSMA7 HSPC	9536;	9606.ENSP00000359910;
Q93096	TP4A1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein tyrosine phosphatase type IVA 1 (EC 3.1.3.48) (PTP(CAAXI)) (Protein-tyrosine phosphatase 4a1) (Protein-tyrosine phosphatase of regenerating liver 1) (PRL-1)	PTP4A1 PRL1 PTPCAAX1	9634;	
Q13263	TIF1B_HUMAN	reviewed	Evidence at protein level	5 out of 5	Transcription intermediary factor 1-beta (TIF1-beta) (E3 SUMO-protein ligase TRIM28) (EC 2.3.2.27) (KRAB-associated protein 1) (KAP-1) (KRAB-interacting protein 1) (KRIP-1) (Nuclear corepressor KAP-1) (RING finger protein 96) (RING-type E3 ubiquitin transferase TIF1-beta) (Tripartite motif-containing protein 28)	TRIM28 KAP1 RNF96 TIF1B	16384;	9606.ENSP00000253024;
Q8IU80	TMPS6_HUMAN	reviewed	Evidence at protein level	5 out of 5	Transmembrane protease serine 6 (EC 3.4.21.-) (Matriptase-2)	TMPRSS6 UNQ354/PRO618	16517;	9606.ENSP00000371211;
Q99612	KLF6_HUMAN	reviewed	Evidence at protein level	5 out of 5	Krueppel-like factor 6 (B-cell-derived protein 1) (Core promoter element-binding protein) (GC-rich sites-binding factor GBF) (Proto-oncogene BCD1) (Suppressor of tumorigenicity 12 protein) (Transcription factor Zf9)	KLF6 BCD1 COPEB CPBP ST12	2235;	9606.ENSP00000419923;
Q92876	KLK6_HUMAN	reviewed	Evidence at protein level	5 out of 5	Kallikrein-6 (EC 3.4.21.-) (Neurosin) (Protease M) (SP59) (Serine protease 18) (Serine protease 9) (Zyme)	KLK6 PRSS18 PRSS9	6367;	9606.ENSP00000366047;
O95970	LGI1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Leucine-rich glioma-inactivated protein 1 (Epitempin-1)	LGI1 EPT UNQ775/PRO1569	6572;	9606.ENSP00000360472;
